Avadel Pharmaceuticals (AVDL) News Today $10.30 +0.07 (+0.68%) As of 09:40 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock AVDL Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period Following a 34% decline over last year, recent gains may please Avadel Pharmaceuticals plc (NASDAQ:AVDL) institutional ownersJune 10 at 10:42 AM | finance.yahoo.comLifesci Capital Has Bullish Estimate for AVDL Q2 EarningsJune 9 at 1:21 AM | americanbankingnews.comLifesci Capital Has Optimistic Outlook of AVDL Q2 EarningsAvadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) - Equities research analysts at Lifesci Capital boosted their Q2 2025 earnings per share (EPS) estimates for Avadel Pharmaceuticals in a research note issued to investors on Thursday, June 5th. Lifesci Capital analyst M. Belghiti now anticipaJune 9 at 1:20 AM | marketbeat.comBank of America Corp DE Decreases Position in Avadel Pharmaceuticals plc (NASDAQ:AVDL)Bank of America Corp DE decreased its holdings in shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by 82.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 83,039 shares of the company's stJune 8 at 3:22 AM | marketbeat.comAvadel Pharmaceuticals Receives Orphan Drug Designation for LUMRYZ in IHJune 6, 2025 | msn.comAvadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic HypersomniaJune 5, 2025 | globenewswire.comNuveen Asset Management LLC Purchases 54,773 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL)Nuveen Asset Management LLC grew its position in Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by 21.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 305,462 shares of the company's stockJune 2, 2025 | marketbeat.comAvadel Pharmaceuticals plc (AVDL) Showcases LUMRYZ Success with 14 Abstracts, 4 Oral Presentations at SLEEP 2025May 30, 2025 | msn.comAvadel Pharmaceuticals to Present New Data on LUMRYZ™ (sodium oxybate) For Extended-Release Oral Suspension at SLEEP 2025May 29, 2025 | globenewswire.comAvadel Pharmaceuticals to Present at the Jefferies Global Healthcare ConferenceMay 29, 2025 | globenewswire.comPVG Asset Management Corp Acquires Shares of 34,040 Avadel Pharmaceuticals plc (NASDAQ:AVDL)PVG Asset Management Corp acquired a new stake in shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 34,040 shares of the company's stock, valued at approximately $358,000. AvadelMay 27, 2025 | marketbeat.comAvadel Pharmaceuticals plc (NASDAQ:AVDL) Given Average Recommendation of "Buy" by BrokeragesAvadel Pharmaceuticals plc (NASDAQ:AVDL - Get Free Report) has been assigned an average rating of "Buy" from the seven analysts that are currently covering the stock, MarketBeat reports. Seven research analysts have rated the stock with a buy rating. The average 12-month target price among brokersMay 27, 2025 | marketbeat.comWoodline Partners LP Has $5.27 Million Position in Avadel Pharmaceuticals plc (NASDAQ:AVDL)Woodline Partners LP lessened its position in Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by 70.3% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 501,821 shares of the company's stock after selling 1,185,492 shares duringMay 26, 2025 | marketbeat.comMillennium Management LLC Raises Stake in Avadel Pharmaceuticals plc (NASDAQ:AVDL)Millennium Management LLC raised its position in Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by 23.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,212,004 shares of the company's stock after acquiringMay 26, 2025 | marketbeat.comTwo Seas Capital LP Has $45.16 Million Stake in Avadel Pharmaceuticals plc (NASDAQ:AVDL)Two Seas Capital LP raised its holdings in Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by 90.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,296,449 shares of the company's stock afterMay 23, 2025 | marketbeat.com40,000 Shares in Avadel Pharmaceuticals plc (NASDAQ:AVDL) Purchased by Zimmer Partners LPZimmer Partners LP acquired a new position in shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 40,000 shares of the company's stock, valued at approxMay 23, 2025 | marketbeat.comAvadel Pharmaceuticals plc (NASDAQ:AVDL) Shares Bought by Northern Trust CorpNorthern Trust Corp increased its holdings in Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by 11.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 658,582 shares of the company's stock aftMay 22, 2025 | marketbeat.comDeutsche Bank AG Raises Stock Holdings in Avadel Pharmaceuticals plc (NASDAQ:AVDL)Deutsche Bank AG raised its holdings in Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by 6.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 508,696 shares of the company's stock after purchasiMay 21, 2025 | marketbeat.comTang Capital Management LLC Has $15.74 Million Position in Avadel Pharmaceuticals plc (NASDAQ:AVDL)Tang Capital Management LLC boosted its holdings in Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by 21.7% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,497,500 shares of the company's stock after purchaMay 20, 2025 | marketbeat.comPolar Capital Holdings Plc Cuts Stake in Avadel Pharmaceuticals plc (NASDAQ:AVDL)Polar Capital Holdings Plc reduced its position in Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by 8.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,414,200 shares of the company's sMay 17, 2025 | marketbeat.comAvadel Pharmaceuticals Appoints Susan Rodriguez as Chief Operating OfficerMay 15, 2025 | nasdaq.comAvadel Pharmaceuticals: Moving Nicely Through An 'Inflection Year'May 15, 2025 | seekingalpha.comJanus Henderson Group PLC Acquires 753,332 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL)Janus Henderson Group PLC increased its holdings in shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by 5.7% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 14,080,219 shares of the company's stock after purchasing an additional 753,332 shMay 15, 2025 | marketbeat.comAvadel Pharmaceuticals plc: Avadel Pharmaceuticals Expands Leadership Team with Appointment of Susan Rodriguez as Chief Operating OfficerMay 14, 2025 | finanznachrichten.deJ. Goldman & Co LP Sells 96,933 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL)J. Goldman & Co LP lessened its stake in shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by 70.6% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 40,347 shares of the company's stock after selling 96,933 shares during the period. J. GoldmanMay 14, 2025 | marketbeat.comAvadel Pharmaceuticals Expands Leadership Team with Appointment of Susan Rodriguez as Chief Operating OfficerMay 13, 2025 | globenewswire.comAvadel Pharmaceuticals to Present at the H.C. Wainwright 3rd Annual BioConnect Investor ConferenceMay 13, 2025 | globenewswire.comLeerink Partnrs Issues Positive Estimate for AVDL EarningsAvadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) - Stock analysts at Leerink Partnrs lifted their Q2 2025 earnings per share estimates for shares of Avadel Pharmaceuticals in a research note issued on Wednesday, May 7th. Leerink Partnrs analyst M. Goodman now forecasts that the company willMay 13, 2025 | marketbeat.comAnalysts Are Updating Their Avadel Pharmaceuticals plc (NASDAQ:AVDL) Estimates After Its First-Quarter ResultsMay 10, 2025 | finance.yahoo.comAvadel Pharmaceuticals (NASDAQ:AVDL) Receives Buy Rating from Needham & Company LLCNeedham & Company LLC reissued a "buy" rating and issued a $19.00 target price on shares of Avadel Pharmaceuticals in a report on Thursday.May 10, 2025 | marketbeat.comFirst Trust Advisors LP Grows Stock Position in Avadel Pharmaceuticals plc (NASDAQ:AVDL)First Trust Advisors LP boosted its stake in shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by 779.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 106,729 shares of the company's stockMay 10, 2025 | marketbeat.comAvadel Pharmaceuticals (NASDAQ:AVDL) Shares Gap Up Following Better-Than-Expected EarningsAvadel Pharmaceuticals (NASDAQ:AVDL) Shares Gap Up After Earnings BeatMay 9, 2025 | marketbeat.comEnvestnet Asset Management Inc. Sells 32,618 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL)Envestnet Asset Management Inc. cut its holdings in Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by 54.0% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 27,825 shares of the company's stMay 9, 2025 | marketbeat.comBraidwell LP Grows Position in Avadel Pharmaceuticals plc (NASDAQ:AVDL)Braidwell LP boosted its holdings in Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by 21.2% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 4,105,726 shares of the company's stock after buying an additional 716,787 shares during thMay 8, 2025 | marketbeat.comAvadel Pharmaceuticals PLC (AVDL) Q1 2025 Earnings Call Highlights: Record Revenue Growth and ...May 8, 2025 | finance.yahoo.comAvadel Pharmaceuticals reports Q1 EPS (5c), consensus (7c)May 7, 2025 | msn.comAvadel Pharmaceuticals sees FY25 revenue $255M-$265M, consensus $249.16MMay 7, 2025 | msn.comAppeals court reverses-in-part, vacates-in part ruling in Avadel-Jazz fightMay 7, 2025 | finance.yahoo.comAvadel Pharmaceuticals plc (AVDL) Q1 2025 Earnings Call TranscriptMay 7, 2025 | seekingalpha.comAvadel Pharmaceuticals (NASDAQ:AVDL) Shares Up 3.4% - Here's What HappenedAvadel Pharmaceuticals (NASDAQ:AVDL) Stock Price Up 3.4% - Time to Buy?May 7, 2025 | marketbeat.comAvadel Pharmaceuticals plc: Avadel Pharmaceuticals Announces Favorable Ruling in Appeal of Delaware Court InjunctionMay 7, 2025 | finanznachrichten.deAvadel Pharmaceuticals plc: Avadel Pharmaceuticals Reports First Quarter 2025 Financial Results and Raises GuidanceMay 7, 2025 | finanznachrichten.deAvadel Pharmaceuticals Reports First Quarter 2025 Financial Results and Raises GuidanceMay 7, 2025 | globenewswire.comAvadel Pharma gains after appeals court ruling in Lumryz case with Jazz PharmaMay 7, 2025 | msn.com6AVDL : Earnings Outlook For Avadel PharmaceuticalsMay 7, 2025 | benzinga.comAvadel Pharmaceuticals Announces Favorable Ruling in Appeal of Delaware Court InjunctionMay 6, 2025 | globenewswire.comBarclays PLC Sells 222,271 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL)Barclays PLC lessened its stake in shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by 56.6% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 170,420 shares of the company's stock after selling 222,271 shares during the period. Barclays PLC owMay 5, 2025 | marketbeat.comAvadel Pharmaceuticals (AVDL) to Release Earnings on WednesdayAvadel Pharmaceuticals (NASDAQ:AVDL) will be releasing its Q1 2025 earnings before the market opens on Wednesday, May 7. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-7-avadel-pharmaceuticals-plc-stock/)May 4, 2025 | marketbeat.comAvadel Pharmaceuticals plc (NASDAQ:AVDL) Given Consensus Recommendation of "Buy" by AnalystsAvadel Pharmaceuticals plc (NASDAQ:AVDL - Get Free Report) has received a consensus recommendation of "Buy" from the eight analysts that are presently covering the company, Marketbeat Ratings reports. Eight research analysts have rated the stock with a buy recommendation. The average 1-year targetMay 3, 2025 | marketbeat.comMML Investors Services LLC Grows Position in Avadel Pharmaceuticals plc (NASDAQ:AVDL)MML Investors Services LLC grew its holdings in shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL - Free Report) by 22.7% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 167,306 shares of the company's stock after buying aMay 2, 2025 | marketbeat.com Get Avadel Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AVDL and its competitors with MarketBeat's FREE daily newsletter. Email Address AVDL Media Mentions By Week AVDL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AVDL News Sentiment▼0.931.01▲Average Medical News Sentiment AVDL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AVDL Articles This Week▼105▲AVDL Articles Average Week Get Avadel Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AVDL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MRUS News Today ACAD News Today ACLX News Today SWTX News Today RARE News Today PTGX News Today SRRK News Today ALVO News Today MTSR News Today CPRX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AVDL) was last updated on 6/11/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Avadel Pharmaceuticals plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Avadel Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AVDL Stock Free AVDL Stock Alerts